• Home
  • ARCN
    • About ARCN
    • Partner Institutions
    • Scientists
    • Leadership and Administration
    • Contacts
  • DZL
    • Member of the DZL
    • DZL Partner Sites
      • ARCN
      • BREATH
      • CPC-M
      • TLRC
      • UGMLC
    • Lung Information Service
    • DZL Academy
  • Research
    • Clinical trials
    • Asthma & Allergy
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Diffuse Parenchymal Lung Disease (DPLD)
    • End-stage lung disease
    • Acute Lung Injury and Pneumonia
    • Pulmonary Hypertension
    • Cystic Fibrosis
    • Platform Imaging
    • Platform Biobanking
    • Publications
  • News & Media
    • News
    • Events
    • Media & Downloads
  • Careers
    • Job offers
  • Deutsch
  • Home
  • ARCN
    • About ARCN
    • Partner Institutions
    • Scientists
    • Leadership and Administration
    • Contacts
  • DZL
    • Member of the DZL
    • DZL Partner Sites
      • ARCN
      • BREATH
      • CPC-M
      • TLRC
      • UGMLC
    • Lung Information Service
    • DZL Academy
  • Research
    • Clinical trials
    • Asthma & Allergy
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Diffuse Parenchymal Lung Disease (DPLD)
    • End-stage lung disease
    • Acute Lung Injury and Pneumonia
    • Pulmonary Hypertension
    • Cystic Fibrosis
    • Platform Imaging
    • Platform Biobanking
    • Publications
  • News & Media
    • News
    • Events
    • Media & Downloads
  • Careers
    • Job offers

Tag: COPD

How the immunoproteasome sustains chronic inflammation in COPD

Published 3. April 2023
Categorised as News Tagged Biomarker, Chronic inflammation, COPD, Diagnosis, dzl, Immune cells, Immunoproteasome, Inflammatory response, Lung function, Mononuclear blood cells, Proteasome, Smoking, Treatment

Predictions based on genetic risk indicate poorer lung function in early childhood

Published 28. March 2023
Categorised as News Tagged Chronic obstructive pulmonary disease, Clinical care, COPD, dzl, Early childhood, Environmental risks, FEV1, Genetic risk, GNN, Lung function, NEJM, Polygenic risk score, Preterm infants, PRS, Smoking, Therapeutic approaches

  • ARCN
    • About ARCN
    • Partner Institutions
    • Scientists
    • Leadership and Administration
    • Contacts
  • DZL
    • Member of the DZL
    • DZL Partner Sites
    • Lung Information Service
    • DZL Academy
  • Research
    • Clinical trials
    • Asthma & Allergy
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Lung Cancer
    • Diffuse Parenchymal Lung Disease (DPLD)
    • End-stage lung disease
    • Acute Lung Injury and Pneumonia
    • Pulmonary Hypertension
    • Cystic Fibrosis
    • Platform Imaging
    • Platform Biobanking
    • Publications
  • News & Media
    • News
    • Events
    • Media & Downloads
  • Careers
    • Job offers

  • Copyright © 2021 by ARCN. All rights reserved Imprint | Protection of privacy